FDA Orange Book · active-ingredient family
Calcium chloride; magnesium chloride; potassium chloride; sodium chloride
Calcium chloride; magnesium chloride; potassium chloride; sodium chloride is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:PLEGISOL IN PLASTIC CONTAINER · NDA 018608
1
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PLEGISOL IN PLASTIC CONTAINERRLD | HOSPIRA | NDA 018608 | AT | Feb 26, 1982 |
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CARDIOPLEGIC IN PLASTIC CONTAINER | FRESENIUS KABI USA | ANDA 214623 | AT | Feb 18, 2022 | |
| CARDIOPLEGIC IN PLASTIC CONTAINER | BAXTER HLTHCARE | ANDA 075323 | AT | Apr 21, 2000 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Calcium chloride; magnesium chloride; potassium chloride; sodium chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
